23 May 2013
Keywords: gensia, halts, protara, trial, panel, advice, pharmaceuticals
Article | 22 August 1994
Gensia Pharmaceuticals has reported that an outside panel monitoring a Phase III trial of its protara heart drug in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.